also on other fortune lists

company facts

f500 stats

Fortune 500

Joe Raedle—Getty Images


CVS Health


It was a big year for ever-bigger CVS Health, which notched a 5% increase in annual revenue, to $195 billion, as it closed its $70 billion acquisition of insurer Aetna. The Rhode Island retailer saw particular strength in its pharmacy business—thanks to more network claims and increased prescription volume—even as downward price pressure continued. But all eyes remain on Aetna, and so far, it’s tough sledding. An underwhelming February forecast, and acknowledgment that CVS would have to invest in Aetna as much as it expected to save in the deal, disappointed investors and led to its share price dropping 20% to below $55. Can CVS cure what ails it? That depends in part on what happens in Washington. In May, CEO Larry Merlo joined industry peers in criticizing proposed “Medicare for All” legislation that would eliminate private insurers and disrupt the American health care system.

Looking for leads, investment insights, or competitive intelligence?


Larry J. Merlo

CEO Title

President, Chief Executive Officer & Director


Health Care


Health Care: Pharmacy and Other Services

HQ Location

Woonsocket, R.I.

Years on Fortune 500 List




Acquired Aetna (2017 rank: 49), Nov. 28, 2018.
Key Financials (Last Fiscal Year)
$ millions% change
Revenues ($M)$194,5795.3%
Profits ($M)$-594.0-109.0%
Assets ($M)$196,456
Total Stockholder Equity ($M)$58,225
Profit Ratios
Profit as % of Revenues-0.3%
Profits as % of Assets-0.3%
Profits as % of Stockholder Equity-1.0%
Earnings Per Share (Last Fiscal Year)
Earnings Per Share ($)-0.57
EPS % Change (from 2017)-108.9%
EPS % Change (5 year annual rate)-
EPS % Change (10 year annual rate)-
Total Return
Total Return to Investors (2018)-7.0%
Total Return to Investors (5 year, annualized)0.3%
Total Return to Investors (10 year, annualized)10.4%
()0.00 0.00 (0)
  • Previous Close:
  • Market Cap: NaNB
  • Next Earnings Date:
  • High:
  • Low:
  • 52 Week High:
  • 52 Week Low:
  • 52 Week Change %: 0.00
  • P/E Ratio: n/a
  • EPS:
  • Dividend Yield: n/a

News about CVS Health

Private Insurers Are Afraid of Medicare for All. They Should Be Excited

One-third of the current Medicare system is run by private companies.

Read More →
These Stocks Are Born to Run

When it comes to investing, the U.S. market remains a bright spot. We scoured the Fortune 500 for four all-American stocks that still have upside.

Read More →
Walgreens to Clear Shelf Space for CBD Products in 1500 Stores

The move comes a week after CVS said it will sell CBD products in 800 of its stores.

Read More →